Purpose . To examine temporal patterns of visual acuity (VA) response to pooled 0.3 mg/0.5 mg ranibizumab treatment in patients with age-related macular degeneration and identify potential baseline predictors of response. Design . Retrospective analysis. Methods . Results from 1824 ranibizumab-tr…